Crucial clues

被引：6

作者：

Deweerdt, Sarah

机构：

[1] Sarah Deweerdt is a freelance science writer in Seattle,

[2] Washington.,undefined

来源：

NATURE | 2014年 / 513卷 / 7517期

关键词：

LUNG-CANCER; NEVER SMOKERS; T790M MUTATIONS; GEFITINIB;

D O I：

10.1038/513S12a

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

页码：S12 / S13

页数：2

共 7 条

[1] Lung cancer in never smokers - A review [J].

Couraud, Sebastien ;

Zalcman, Gerard ;

Milleron, Bernard ;

Morin, Franck ;

Souquet, Pierre-Jean .

EUROPEAN JOURNAL OF CANCER, 2012, 48 (09) :1299-1311

[2] Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations [J].

Gazdar, Adi ;

Robinson, Linda ;

Oliver, Dwight ;

Xing, Chao ;

Travis, William D. ;

Soh, Junichi ;

Toyooka, Shinichi ;

Watumull, Lori ;

Xie, Yang ;

Kernstine, Kemp ;

Schiller, Joan H. .

JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) :456-463

[3] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[4] Screening for Germline EGFR T790M Mutations Through Lung Cancer Genotyping [J].

Oxnard, Geoffrey R. ;

Miller, Vincent A. ;

Robson, Mark E. ;

Azzoli, Christopher G. ;

Pao, William ;

Ladanyi, Marc ;

Arcila, Maria E. .

JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) :1049-1052

[5] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].

Paez, JG ;

Jänne, PA ;

Lee, JC ;

Tracy, S ;

Greulich, H ;

Gabriel, S ;

Herman, P ;

Kaye, FJ ;

Lindeman, N ;

Boggon, TJ ;

Naoki, K ;

Sasaki, H ;

Fujii, Y ;

Eck, MJ ;

Sellers, WR ;

Johnson, BE ;

Meyerson, M .

SCIENCE, 2004, 304 (5676) :1497-1500

[6] EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib [J].

Pao, W ;

Miller, V ;

Zakowski, M ;

Doherty, J ;

Politi, K ;

Sarkaria, I ;

Singh, B ;

Heelan, R ;

Rusch, V ;

Fulton, L ;

Mardis, E ;

Kupfer, D ;

Wilson, R ;

Kris, M ;

Varmus, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) :13306-13311

[7] Lung cancer in never smokers - a different disease [J].

Sun, Sophie ;

Schiller, Joan H. ;

Gazdar, Adi F. .

NATURE REVIEWS CANCER, 2007, 7 (10) :778-790

← 1 →